Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extracorporeal Photopheresis in Steroid-Refractory Acute and Chronic GVHD
2015-001550-14Phase 2Terminated
- Sponsor
- Bispebjerg and Frederiksberg Hospital
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of methoxsalen in graft-versus-host disease (GVHD), sponsored by Bispebjerg and Frederiksberg Hospital. Primary endpoint: Response in acute GVHD. Started Apr 2015; status: terminated.
02
Drugs
methoxsalen
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on 2015-001550-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001550-14.